医疗保健定价和获取的伦理:一个社会正义问题

Richard Boudreau
{"title":"医疗保健定价和获取的伦理:一个社会正义问题","authors":"Richard Boudreau","doi":"10.31579/2639-4162/026","DOIUrl":null,"url":null,"abstract":"In most countries in the developed world, healthcare is considered a right, not a privilege. Access to appropriate medical services, including pharmaceuticals, is viewed as a natural part of the commitment of the government to its people. In the United States, though, the focus on pharmaceutical development has led to a kind of “free-for-all” in the industry, where each company strives to produce new products at an alarming rate, with the end goal of profitability and competitive advantage.","PeriodicalId":93288,"journal":{"name":"General medicine and clinical practice","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Ethics of Pricing and Access to Healthcare: A Social Justice Issue\",\"authors\":\"Richard Boudreau\",\"doi\":\"10.31579/2639-4162/026\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"In most countries in the developed world, healthcare is considered a right, not a privilege. Access to appropriate medical services, including pharmaceuticals, is viewed as a natural part of the commitment of the government to its people. In the United States, though, the focus on pharmaceutical development has led to a kind of “free-for-all” in the industry, where each company strives to produce new products at an alarming rate, with the end goal of profitability and competitive advantage.\",\"PeriodicalId\":93288,\"journal\":{\"name\":\"General medicine and clinical practice\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-09-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"General medicine and clinical practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31579/2639-4162/026\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"General medicine and clinical practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31579/2639-4162/026","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

在大多数发达国家,医疗保健被视为一种权利,而不是一种特权。获得适当的医疗服务,包括药品,被视为政府对其人民承诺的自然组成部分。然而,在美国,对药物开发的关注导致了该行业的一种“混战”,每家公司都以惊人的速度努力生产新产品,最终目标是盈利和竞争优势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The Ethics of Pricing and Access to Healthcare: A Social Justice Issue
In most countries in the developed world, healthcare is considered a right, not a privilege. Access to appropriate medical services, including pharmaceuticals, is viewed as a natural part of the commitment of the government to its people. In the United States, though, the focus on pharmaceutical development has led to a kind of “free-for-all” in the industry, where each company strives to produce new products at an alarming rate, with the end goal of profitability and competitive advantage.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信